Hsbc Holdings PLC Vertex Pharmaceuticals Inc Put Options Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $9.51 Million - $11.7 Million	-24,200 Reduced 59.02%	16,800 $7.87 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $2.45 Million - $2.68 Million	-6,000 Reduced 12.77%	41,000 $17.1 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $274,400 - $328,544	800 Added 1.73%	47,000 $19.1 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $5.28 Million - $5.65 Million	15,600 Added 50.98%	46,200 $16.1 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $597,398 - $668,629	-1,900 Reduced 5.85%	30,600 $10.8 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $6.03 Million - $6.88 Million	21,300 Added 190.18%	32,500 $10.2 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $342,912 - $385,776	-1,200 Reduced 9.68%	11,200 $3.23 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $2.03 Million - $2.26 Million	7,400 Added 148.0%	12,400 $3.62 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $4.86 Million - $6.06 Million	-20,700 Reduced 80.54%	5,000 $1.42 Million
Q4 2020 Feb 25, 2021	BUY	$207.01 - $276.09 $683,133 - $911,096	3,300 Added 14.73%	25,700 $6.07 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $255,650 - $303,100	-1,000 Reduced 4.27%	22,400 $6.12 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $744,084 - $976,140	3,300 Added 16.42%	23,400 $6.79 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $49.7 Million - $61.7 Million	-249,000 Reduced 92.53%	20,100 $4.76 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $20.7 Million - $27.7 Million	-123,900 Reduced 31.53%	269,100 $58.6 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $1.18 Million - $1.33 Million	7,100 Added 1.84%	393,000 $66.6 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $61 Million - $70.5 Million	370,500 Added 2405.84%	385,900 $70.8 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $234,822 - $269,836	-1,400 Reduced 8.33%	15,400 $2.97 Million
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $90,960 - $106,278	600 Added 3.7%	16,800 $2.74 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $2.4 Million - $2.63 Million	16,200	16,200 $2.46 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account